aTyr Pharma (LIFE)

aTyr Pharma Financial Statements


aTyr Pharma Financial Overview

aTyr Pharma's market cap is currently ―. The company's EPS TTM is $-1.811; its P/E ratio is -1.95; aTyr Pharma is scheduled to report earnings on November 17, 2022, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -12.38M$ -8.64M$ -7.73M$ -10.45M$ -7.20M
EBITDA$ -12.08M$ -8.32M$ -7.40M$ -10.09M$ -6.91M
Net Income Common Stockholders$ -12.15M$ -8.56M$ -7.67M$ -10.39M$ -7.15M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 31.69M$ 36.15M$ 44.06M$ 50.64M$ 98.67M
Total Assets$ 104.78M$ 115.54M$ 123.92M$ 48.99M$ 55.13M
Total Debt$ 994.00K$ 1.29M$ 1.58M$ 1.85M$ 2.13M
Net Debt$ -30.70M$ -34.86M$ -42.48M$ -48.78M$ -96.54M
Total Liabilities$ 6.40M$ 6.41M$ 6.48M$ 8.19M$ 5.60M
Stockholders Equity$ 31.65M$ 32.16M$ 40.98M$ 49.70M$ 98.55M
Cash Flow
Free Cash Flow$ -10.16M$ -8.10M$ -11.53M$ -7.79M$ -5.84M
Operating Cash Flow$ -10.12M$ -8.09M$ -11.47M$ -7.69M$ -5.83M
Investing Cash Flow$ 14.63M$ -49.35M$ -14.85M$ -3.97M$ -23.39M
Financing Cash Flow$ 1.48M$ 28.00K$ 83.87M$ 1.27M$ 24.86M
Currency in USD

aTyr Pharma Earnings and Revenue History

aTyr Pharma Debt to Assets

aTyr Pharma Cash Flow

aTyr Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis